Transcriptional and post-transcriptional control of DNA methyltransferase 3B is regulated by phosphatidylinositol 3 kinase/Akt pathway in human hepatocellular carcinoma cell lines

Journal of Cellular Biochemistry

Volumn 111, Issue 1, 2010, Pages 158-167

  Mei, Chuanzhong ^a   Sun, Lidong ^a   Liu, Yonglei ^a   Yang, Yong ^a   Cai, Xiumei ^a,b   Liu, Mingzhu ^a   Yao, Wantong ^a   Wang, Can ^a   Li, Xin ^a   Wang, Liying ^a,b   Li, Zengxia ^a,b   Shi, Yinghong ^a   Qiu, Shuangjian ^a   Fan, Jia ^a   Zha, Xiliang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

DNA methyltransferase (DNMT); Human hepatocellular carcinoma; PI3K Akt

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; DNA METHYLTRANSFERASE 3B; HUR PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; EPIGENETICS; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMONES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; GENE EXPRESSION REGULATION; HUMANS; LIVER NEOPLASMS; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 77957122940     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22684     Document Type: Article

References (47)

1. Alexia C, Bras M, Fallot G, Vadrot N, Daniel F, Lasfer M, Tamouza H, Groyer A. 2006. Pleiotropic effects of PI-3′ kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis. Ann NY Acad Sci 1090:1-17. (Pubitemid 47092103)
2. Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, MacLeod AR. 2002. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem 277:28176-28181. (Pubitemid 34966771)
3. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J. 2007. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45:42-52.
4. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, Schroeder I, Factor VM, Thorgeirsson SS. 2007. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 117:2713-2722.
5. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, Zhang LJ. 2009. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res 39:177-186.
6. Cotler SJ, Hay N, Xie H, Chen ML, Xu PZ, Layden TJ, Guzman G. 2008. Immunohistochemical expression of components of the Akt-mTORC1 pathway is associated with hepatocellular carcinoma in patients with chronic liver disease. Dig Dis Sci 53:844-849. (Pubitemid 351317087)
7. Cui M, Wen Z, Yang Z, Chen J, Wang F. 2009. Estrogen regulates DNA methyltransferase 3B expression in Ishikawa endometrial adenocarcinoma cells. Mol Biol Rep 36:2201-2207.
8. Dai R, Chen R, Li H. 2009. Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells. Int J Oncol 34:1749-1757.
9. de Silanes IL, Gorospe M, Taniguchi H, Abdelmohsen K, Srikantan S, Alaminos M, Berdasco M, Urdinguio RG, Fraga MF, Jacinto FV, Esteller M. 2009. The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA. Nucleic Acids Res 37:2658-2671.
10. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R. 2008. miR-148 targets human DNMT3b protein coding region. RNA 14:872-877.
11. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW. 1999. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 59:2302-2306.
12. Esteller M. 2007. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8:286-298. (Pubitemid 46439286)
13. Esteller M. 2008. Epigenetics in cancer. N Engl J Med 358:1148-1159.
14. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104:15805-15810.
15. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G. 2009. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113:6411-6418.
16. Girault I, Tozlu S, Lidereau R, Bieche I. 2003. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 9:4415-4422.
17. Hartmann W, Digon-Sontgerath B, Koch A, Waha A, Endl E, Dani I, Denkhaus D, Goodyer CG, Sorensen N, Wiestler OD, Pietsch T. 2006. Phosphatidylinositol 3′-kinase/AKT signaling is activated in medulloblastoma cell proliferation and is associated with reduced expression of PTEN. Clin Cancer Res 12:3019-3027.
18. Herman JG, Baylin SB. 2003. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054. (Pubitemid 37448928)
19. Hervouet E, Debien E, Campion L, Charbord J, Menanteau J, Vallette FM, Cartron PF. 2009a. Folate supplementation limits the aggressiveness of glioma via the remethylation of DNA repeats element and genes governing apoptosis and proliferation. Clin Cancer Res 15:3519-3529.
20. Hervouet E, Vallette FM, Cartron PF. 2009b. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics 4:487-499.
21. Hodge DR, Cho E, Copeland TD, Guszczynski T, Yang E, Seth AK, Farrar WL. 2007. IL-6 enhances the nuclear translocation of DNA cytosine-5- methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics 4:387-398.
22. Huynh H, Nguyen TT, Chow KH, Tan PH, Soo KC, Tran E. 2003. Overexpression of the mitogen-activated protein kinase (MAPK) kinase (MEK)- MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis. BMC Gastroenterol 3:19.
23. Jain S, Singhal S, Lee P, Xu R. 2010. Molecular genetics of hepatocellular neoplasia. Am J Transl Res 2:105-118.
24. Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW. 2005. Upregulation of DNA methyltransferase 3B expression in endometrial cancers. Gynecol Oncol 96:531-538.
25. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y, Yuasa Y. 2005. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 385:557-564. (Pubitemid 40165090)
26. Kanai Y, Hirohashi S. 2007. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28:2434-2442.
27. Kondo Y, Shen L, Suzuki S, Kurokawa T, Masuko K, Tanaka Y, Kato H, Mizuno Y, Yokoe M, Sugauchi F, Hirashima N, Orito E, Osada H, Ueda R, Guo Y, Chen X, Issa JP, Sekido Y. 2007. Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res 37:974-983.
28. Kubarek L, Kozlowska A, Przybylski M, Lianeri M, Jagodzinski PP. 2009. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells. Biomed Pharmacother 63:586-591.
29. Lin HC, Song TY, Hu ML. 2009. S-Adenosylhomocysteine promotes the invasion of C6 glioma cells via increased secretion of matrix metalloproteinase- 2 in murine microglial BV2 cells. Toxicol Sci 112:322-330.
30. Liu X, Shi Y, Woods KW, Hessler P, Kroeger P, Wilsbacher J, Wang J, Wang JY, Li C, Li Q, Rosenberg SH, Giranda VL, Luo Y. 2008. Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression. Neoplasia 10:828-837.
31. Mende I, Malstrom S, Tsichlis PN, Vogt PK, Aoki M. 2001. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 20:4419-4423. (Pubitemid 32726886)
32. Montiel-Duarte C, Cordeu L, Agirre X, Roman-Gomez J, Jimenez-Velasco A, Jose-Eneriz ES, Garate L, Andreu EJ, Calasanz MJ, Heiniger A, Torres A, Prosper F. 2008. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leuk Res 32:709-716.
33. Okano M, Xie S, Li E. 1998. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 19:219-220.
34. Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-257.
35. Patra SK, Patra A, Zhao H, Dahiya R. 2002. DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 33:163-171. (Pubitemid 34195197)
36. Phillips JM, Burgoon LD, Goodman JI. 2009. Phenobarbital elicits unique, early changes in the expression of hepatic genes that affect critical pathways in tumor-prone B6C3F1 mice. Toxicol Sci 109:193-205.
37. Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D, Milanini-Mongiat J, Pages G, O'Rourke DM, Bernhard E, Maity A. 2004. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 15:4841-4853.
38. Qureshi HY, Ahmad R, Sylvester J, Zafarullah M. 2007. Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in human chondrocytes. Cell Signal 19:1643-1651. (Pubitemid 46935421)
39. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. 2003. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33:61-65.
40. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. 2002. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc Natl Acad Sci USA 99:10060-10065.
41. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S. 2003. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 105:527-532.
42. Sun L, Zhao H, Xu Z, Liu Q, Liang Y, Wang L, Cai X, Zhang L, Hu L, Wang G, Zha X. 2007. Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation. Cell Signal 19:2255-2263.
43. Tryndyak VP, Muskhelishvili L, Kovalchuk O, Rodriguez-Juarez R, Montgomery B, Churchwell MI, Ross SA, Beland FA, Pogribny IP. 2006. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: Implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis 27:1713-1720.
44. Wymann MP, Marone R. 2005. Phosphoinositide 3-kinase in disease: Timing, location, and scaffolding. Curr Opin Cell Biol 17:141-149. (Pubitemid 40380937)
45. Xie S, Wang Z, Okano M, Nogami M, Li Y, He WW, Okumura K, Li E. 1999. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene 236:87-95.
46. Yanagisawa Y, Ito E, Yuasa Y, Maruyama K. 2002. The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. Biochim Biophys Acta 1577:457-465.
47. Zhang X, Li Y, Dai C, Yang J, Mundel P, Liu Y. 2003. Sp1 and Sp3 transcription factors synergistically regulate HGF receptor gene expression in kidney. Am J Physiol Renal Physiol 284:F82-F94. (Pubitemid 35471288)